OIA
SYRS

OneDigital Investment Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

OneDigital Investment Advisors’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,008
Closed -$107K – 726
2020
Q2 		$107K Buy
+1,008
New +$90.5K 0.01% 583

Other funds holding SYRS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OneDigital Investment Advisors's SYRS Position: Q3 2020 in Review

OneDigital Investment Advisors sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q3 2020, closing a stake of 1,008 shares — an estimated $107K sold.

OneDigital Investment Advisors first reported a position in SYRS in Q2 2020 and held it in 1 quarter. The position peaked at $107K in Q2 2020. 93 funds tracked by Wall St. Rank hold SYRS as of Q3 2020.

  • OneDigital Investment Advisors reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • OneDigital Investment Advisors sold 1,008 Syros Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $107K.
  • OneDigital Investment Advisors first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • OneDigital Investment Advisors's Syros Pharmaceuticals, Inc. Common Stock position peaked at $107K in Q2 2020.
  • 93 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on OneDigital Investment Advisors's 13F filing for Q3 2020, filed 9 Oct 2020.